Idiopathic hypereosinophilic syndromes

IGSS Immuno-gold silver stain IHC Immunohistochemistry IHES Idiopathic hypereosinophilic syndrome... 

Malbrain ML, Van den Bergh H, Zachee E Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome complete haematological and cytogenetic remission induced by interferon-a in a case with a unique chromosomal abnormality. Br J Haematol 1996 92 176-83. 

CiUoni D, Messa E, MartineUi G, et al. WTl transcript amount discriminates secondary or reactive eosinophiha from idiopathic hypereosinophilic syndrome or chronic eosinophihc leukemia. Leukemia 2007 21 1442-1450. 

Fauci AS, Harley JB, Roberts WC, et al. The idiopathic hypereosinophilic syndrome clinical, pathophysiologic and therapeutic considerations. Ann Intern Med 1982 97 78-92. 

Cools J, DeAngelo DJ, GotUb J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIPILI genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2(X)3 348 1201-1214. 

Griffin JH, Leung J, Bruner RJ, et al. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci U S A 2003 1(X) 7830 835. 

---